Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
about
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking.HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
P2860
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@en
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@nl
type
label
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@en
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@nl
prefLabel
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@en
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer.
@nl
P2093
P2860
P50
P356
P1476
Cross-activating c-Met/β1 inte ...... invasive resistance in cancer
@en
P2093
Alan Nguyen
Andrej Sali
Arman Jahangiri
Brandon Imber
Catherine C Park
Dina Schneidman-Duhovny
Gabriele Bergers
Garima Yagnik
Jonathan Rick
P2860
P304
E8685-E8694
P356
10.1073/PNAS.1701821114
P407
P577
2017-09-26T00:00:00Z